Roivant Sciences Ltd. on ABUS, Oct 5, 2026

Roivant Sciences Ltd. now owns 19.5%. It has said it may push for changes.

Date
Oct 5, 2026
Who
Roivant Sciences Ltd.
Fund
ABUS - Arbutus Biopharma Corp
Stake
19.5% (29,880,079 shares)
Type of notice
Updated notice
Document number
0001140361-26-038693

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to ABUS